학술논문
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
Document Type
Article
Author
Danese, S.; Vermeire, S.; Zhou, W.; Pangan, A.L.; Sanchez Gonzalez, Y.; Huang, B.; Xie, W.; Liu, J.; Weinreich, M.A.; Siffledeen, J.; Greenbloom, S.; Hébuterne, X.; D'Haens, G.; Nakase, H.; Panés, J.; Higgins, P.D.R.; Juillerat, P.; Lindsay, J.O.; Loftus, E.V.; Sandborn, W.J.; Reinisch, W.; Chen, M.-H.; Panaccione, R.
Source
In: The Lancet . (The Lancet, 4 June 2022, 399(10341):2113-2128)
Subject
Language
English
ISSN
1474547X
01406736
01406736